RemeGen Co., Ltd. provided earnings guidance for the period from January 1, 2023 to December 31, 2023. For the period, Company expects operating revenue for the year of 2023 is estimated to be approximately RMB 1,080 million, representing an increase of approximately RMB 310 million in revenue as compared with the same period of last year and a year-on-year increase of approximately 40%. Net loss attributable to owners of the parent company for the year of 2023 will be approximately RMB 1,550 million, representing an increase of RMB 552 million in loss as compared with the same period of last year and a year-on-year increase of approximately 55% in loss.

Net loss attributable to owners of the parent company after deducting the non-recurring gains or losses for the year of 2023 will be approximately RMB 1,580 million, representing an increase of RMB 464 million in loss as compared with the same period of last year and a year-on-year increase of approximately 42% in loss.